Achilles Therapeutics Funding: $127M Raised, Series B (2021)
Achilles Therapeutics is based in Stevenage, Hertfordshire, United Kingdom. It has raised $127M in total funding. Latest round: Series B.
Achilles Therapeutics funding overview
Achilles Therapeutics is based in Stevenage, Hertfordshire, United Kingdom. Achilles Therapeutics has raised $127M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in June 2021. The round record for Achilles Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include RA Capital Management, Syncona, Forbion, Invus, Perceptive Advisors, Redmile Group. 6 distinct backers are named across the disclosed rounds.
Achilles Therapeutics at a glance
Total raised
$127M
Latest round
Series B
Latest round date
June 2021
Headquarters
Stevenage, Hertfordshire, United Kingdom
Notable investors
RA Capital Management, Syncona, Forbion, Invus, Perceptive Advisors, Redmile Group
Frequently asked about Achilles Therapeutics funding
How much has Achilles Therapeutics raised?
Achilles Therapeutics has raised $127M in total disclosed funding across the rounds on record.
Who has invested in Achilles Therapeutics?
RA Capital Management, Syncona, Forbion, Invus, Perceptive Advisors, Redmile Group are named among the investors backing Achilles Therapeutics.
What was the latest Achilles Therapeutics funding round?
The most recent disclosed round is a Series B, announced in June 2021.
Where is Achilles Therapeutics based?
Achilles Therapeutics is based in Stevenage, Hertfordshire, United Kingdom.
When did Achilles Therapeutics last raise?
The last disclosed Achilles Therapeutics round closed in June 2021 at Series B.
Round data for Achilles Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Stevenage and backer lists below.
